Total lipid profile levels as an indicator of functional outcomes in first-ever acute stroke patients
Keywords:
acute stroke, ischemic stroke, hemorrhagic stroke, nihss, barthel index, MRS, functional outcomesAbstract
A stroke is an abrupt neurological injury caused by alterations in the blood arteries of the brain, resulting in the loss of neurological function. Stroke is the second greatest cause of death in people globally, after ischemic heart disease, and the most prevalent cause of acquired disability. The goal of this study was to determine the levels of lipid profiles in acute stroke patients. From December 2020 until September 2021, the study will be conducted. One hundred males and females’ respondents were included from Ibn-Sena and Al-Salam Teaching hospitals at Mosul City in Iraq. The socio-demographic and clinical data, especially the clinical findings at the time of admission were recorded on a standardized data sheet. Clinical examination and a To confirm the diagnosis, a CT scan of the brain was conducted. A blood sample was taken on the day of admission for total lipid profile analysis. To determine the severity of a stroke, the NIHSS was employed. The patients' functional outcomes were followed for up to three months using a modified Rankin Scale, as follows: good functional (0 - 3), poor functional outcomes (4 - 6).
Downloads
References
Ali, I., Abuissa, M., Alawneh, A., Subeh, O., Abu Sneineh, A., Mousa, S., Deeb, I., & Rayyan, H. (2019). The Prevalence of Dyslipidemia and Hyperglycemia among Stroke Patients: Preliminary Findings. Stroke Research and Treatment, 2019. https://doi.org/10.1155/2019/8194960
Alwan, A., MacLean, D. R., Riley, L. M., D’Espaignet, E. T., Mathers, C. D., Stevens, G. A., & Bettcher, D. (2010). Monitoring and surveillance of chronic non-communicable diseases: Progress and capacity in high-burden countries. The Lancet, 376(9755), 1861–1868. https://doi.org/10.1016/S0140-6736(10)61853-3
Antonios, N., Angiolillo, D. J., & Silliman, S. (2008). Hypertriglyceridemia and ischemic stroke. European Neurology, 60(6), 269–278. https://doi.org/10.1159/000157880
Assarzadegan, F., Tabesh, H., Shoghli, A., Ghafoori Yazdi, M., Tabesh, H., Daneshpajooh, P., & Yaseri, M. (2015). Relation of stroke risk factors with specific stroke subtypes and territories. Iranian Journal of Public Health, 44(10), 1387–1394.
Ayaskanta Kar, C. D., & Malati Murmu, K. M. K. P. (2018). Study of lipid profile in cases of non-diabetic stroke Ayaskanta. International Journal of Advances in Medicine, 9(3), 115–119. https://doi.org/10.3329/kyamcj.v9i3.38782
Demarin, V., Lisak, M., Morović, S., & Cengić, T. (2010). Low high-density lipoprotein cholesterol as the possible risk factor for stroke. Acta Clinica Croatica, 49(4), 429–439.
El-Fawal, B. M., Badry, R., Abbas, W. A., & Ibrahim, A. K. (2019). Stress hyperglycemia and electrolytes disturbance in patients with acute cerebrovascular stroke. Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 55(1), 4–9. https://doi.org/10.1186/s41983-019-0137-0
Frieden, T. R., Cobb, L. K., Leidig, R. C., Mehta, S., & Kass, D. (2020). Reducing Premature Mortality from Cardiovascular and Other Non-Communicable Diseases by One Third: Achieving Sustainable Development Goal Indicator 3.4.1. Global Heart, 15(1), 1–10. https://doi.org/10.5334/GH.531
Jain, M., Jain, A., Yerragondu, N., Brown, R. D., Rabinstein, A., Jahromi, B. S., Vaidyanathan, L., Blyth, B., & Stead, L. G. (2013). The Triglyceride Paradox in Stroke Survivors: A Prospective Study. Neuroscience Journal, 2013(March 2016), 1–7. https://doi.org/10.1155/2013/870608
Kostis, J. B. (2007). The Importance of Managing Hypertension and Dyslipidemia to Decrease Cardiovascular Disease. 297–309. https://doi.org/10.1007/s10557-007-6032-4
Kumar, N., Kumar, R., Singh, S. K. R., & Kumar, J. (2020). A Study On The Clinical Outcome In Ischemic Stroke Patient With Hyperglycemia In A Tertiary Care Hospital Of Southern Bihar. International Journal of Health and Clinical Research, 3(6), 100–107.
Lawler, P. R., Kotrri, G., Koh, M., Goodman, S. G., Farkouh, M. E., Lee, D. S., Austin, P. C., Udell, J. A., & Ko, D. T. (2020). Real-world risk of cardiovascular outcomes associated with hypertriglyceridaemia among individuals with atherosclerotic cardiovascular disease and potential eligibility for emerging therapies. European Heart Journal, 41(1), 86–94. https://doi.org/10.1093/eurheartj/ehz767
Li, Z., Zhang, J., & Luo, Y. (2020). Impact of triglyceride playing on stroke severity correlated to bilirubin. Medicine, 99(36), e21792. https://doi.org/10.1097/MD.0000000000021792
Mankovsky, B. N., & Ziegler, D. (2004). Stroke in patients with diabetes mellitus. Diabetes/Metabolism Research and Reviews, 20(4), 268–287. https://doi.org/10.1002/dmrr.490
Markaki, I., Nilsson, U., Kostulas, K., & Sjöstrand, C. (2014). High cholesterol levels are associated with improved long-term survival after acute ischemic stroke. Journal of Stroke and Cerebrovascular Diseases, 23(1), 1–7. https://doi.org/10.1016/j.jstrokecerebrovasdis.2013.08.009
Nayor, M., & Vasan, R. S. (2016). Recent update to the us cholesterol treatment guidelines: A comparison with international guidelines. Circulation, 133(18), 1795–1806. https://doi.org/10.1161/CIRCULATIONAHA.116.021407
Ogbera, A. O., Oshinaike, O. O., Dada, O., Brodie-Mends, A., & Ekpebegh, C. (2014). Glucose and lipid assessment in patients with acute stroke. International Archives of Medicine, 7(1), 45. https://doi.org/10.1186/1755-7682-7-45
Olsen, T., Christensen, R., Kammersgaard, L., & Andersen, K. (2008). Total cholesterol, severity of stroke, and all-cause mortality. Stroke, 39(3), 61–62. https://doi.org/10.1161/STROKEAHA.107.509356
Pan, S. L., Lien, I. N., & Chen, T. H. H. (2010). Is Higher Serum Total Cholesterol Level Associated With Better Long-Term Functional Outcomes After Noncardioembolic Ischemic Stroke? Archives of Physical Medicine and Rehabilitation, 91(6), 913–918. https://doi.org/10.1016/j.apmr.2010.02.002
Pikija, S., Sztriha, L. K., Killer-Oberpfalzer, M., Weymayr, F., Hecker, C., Ramesmayer, C., Hauer, L., & Sellner, J. (2019). Contribution of Serum Lipid Profiles to Outcome After Endovascular Thrombectomy for Anterior Circulation Ischemic Stroke. Molecular Neurobiology, 56(6), 4582–4588. https://doi.org/10.1007/s12035-018-1391-3
Sadeghi, M., Soleimani, A., Roohafza, H., Yazdekhasti, S., Oveisgharan, S., Talaei, M., & Sarrafzadegan, N. (2017). Cardiovascular disease events and its predictors in women: Isfahan Cohort Study (ICS). Journal of Cardiovascular and Thoracic Research, 9(3), 158–163. https://doi.org/10.15171/jcvtr.2017.27
Sarrafzadegan, N., Talaei, M., Kelishadi, R., Toghianifar, N., Sadeghi, M., Oveisgharan, S., Kabiri, P., Tavassoli, A., Mohammadifard, N., Thomas, G. N., & Marshall, T. (2012). The influence of gender and place of residence on cardiovascular diseases and their risk factors. The Isfahan cohort study. Saudi Medical Journal, 33(5), 533–540.
Setyopranoto, I., Bayuangga, H. F., Panggabean, A. S., Alifaningdyah, S., Lazuardi, L., Dewi, F. S. T., & Malueka, R. G. (2019). Prevalence of stroke and associated risk factors in sleman district of Yogyakarta Special Region, Indonesia. Stroke Research and Treatment, 2019. https://doi.org/10.1155/2019/2642458
Sohail, A., Khatri, I. A., & Mehboob, N. (2013). Effect of dyslipidemia on severity and outcome of stroke using mRS scores in Northern Pakistani population. Rawal Medical Journal, 38(4), 345–350.
Sommers, M. S. (2019). Davis’s Disesases & Disorders A Nursing Therapeutics Manual 6th Edition.
Sreedhar, K., Srikant, B., Joshi, L., & Usha, G. (2010). Lipid profile in non-diabetic stroke - a study of 100 cases. Journal of Association of Physicians of India, 58(9), 547–551.
Tehrani-Banihashemi, A., Moradi-Lakeh, M., Elbcheraoui, C., Charara, R., Khalil, I., Afshin, A., Collison, M., Daoud, F., Krohn, K. J., Chew, A., Cornaby, L., Foreman, K. J., Frostad, J., Kassebaum, N. J., Kemmer, L., Kutz, M., Liu, P., Mirarefin, M., Nguyen, G., … Mokdad, A. H. (2018). Burden of cardiovascular diseases in the Eastern Mediterranean Region, 1990–2015: findings from the Global Burden of Disease 2015 study. International Journal of Public Health, 63, 137–149. https://doi.org/10.1007/s00038-017-1012-3
Vakilian, A., Moghadam-Ahmadi, A., Iranmanesh, F., & Shamsaddini, M. (2019). A Study of Serum Lipid Profile in Ischemic and Hemorrhagic Stroke Patients. Zahedan Journal of Research in Medical Sciences, 21(4). https://doi.org/10.5812/zjrms.87815
Varbo, A., Nordestgaard, B. G., Tybjrg-Hansen, A., Schnohr, P., Jensen, G. B., & Benn, M. (2011). Nonfasting triglycerides, cholesterol, and ischemic stroke in the general population. Annals of Neurology, 69(4), 628–634. https://doi.org/10.1002/ana.22384
Vigili de Kreutzenberg, S., Tiengo, A., & Avogaro, A. (2009). Cerebrovascular disease in diabetes mellitus: The role of carotid intima-media thickness. Nutrition, Metabolism and Cardiovascular Diseases, 19(9), 667–673. https://doi.org/10.1016/j.numecd.2009.03.014
Wada, S., Yoshimura, S., Inoue, M., Matsuki, T., Arihiro, S., Koga, M., Kitazono, T., Makino, H., Hosoda, K., Ihara, M., & Toyoda, K. (2018). Outcome prediction in acute stroke patients by continuous glucose monitoring. Journal of the American Heart Association, 7(8). https://doi.org/10.1161/JAHA.118.008744
Wali, V., & Patil, S. (2016). A comparative study of serum electrolytes and lipid levels in ischaemic and haemorrhagic stroke. International Journal of Research in Medical Sciences, 4(11), 4838–4842. https://doi.org/10.18203/2320-6012.ijrms20163776
Weir, C. J., Sattar, N., Walters, M. R., & Lees, K. R. (2003). Low triglyceride, not low cholesterol concentration, independently predicts poor outcome following acute stroke. Cerebrovascular Diseases, 16(1), 76–82. https://doi.org/10.1159/000070119
World Health Organization. (2018). NCDs and development. Global Status Report on Noncommunicable Diseases.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
